Cover Image
市場調查報告書

口腔粘膜炎:流行病學考察

Oral Mucositis - Epidemiology Insights to 2025

出版商 DelveInsight Business Research LLP 商品編碼 534935
出版日期 內容資訊 英文 68 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
口腔粘膜炎:流行病學考察 Oral Mucositis - Epidemiology Insights to 2025
出版日期: 2017年08月01日 內容資訊: 英文 68 Pages
簡介

本報告提供口腔粘膜炎的流行病學調查分析,提供疾病概要與全球主要市場上流行病學資料 (實際成果與預測) 相關之系統性資訊。

報告概要

  • 概要
    • 口腔粘膜炎的發病率
    • 病理生理學
    • 病因和危險因素
    • 口腔粘膜炎併發症
    • 症狀
    • 診斷
    • 口腔粘膜炎干預
    • 化療誘發性口腔粘膜炎的治療和預防
    • 接受造血幹細胞移植 (HSCT) 的患者的治療和預防選擇
  • 流行病學概要
  • 主要調查結果
  • 主要7個國家的口腔粘膜炎流行病學
    • 前提條件與理論根據
    • 主要7個國家的口腔粘膜炎的發生族群
  • 美國
    • 前提條件與理論根據
    • 發生數量
    • 各等級
    • 性別
    • 各適應症
  • EU5個國家
    • 前提條件與理論根據
  • 法國
    • 前提條件與理論根據
    • 發生數量
    • 各等級
    • 性別
    • 各適應症
  • 德國
    • 前提條件與理論根據
    • 發生數量
    • 各等級
    • 性別
    • 各適應症
  • 義大利
    • 前提條件與理論根據
    • 發生數量
    • 各等級
    • 性別
    • 各適應症
  • 西班牙
    • 前提條件與理論根據
    • 發生數量
    • 各等級
    • 性別
    • 各適應症
  • 英國
    • 前提條件與理論根據
    • 發生數量
    • 各等級
    • 性別
    • 各適應症
  • 日本
    • 前提條件與理論根據
    • 發生數量
    • 各等級
    • 性別
    • 各適應症

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: DIEI0159

DelveInsight's "Oral Mucositis - Epidemiology Forecast To 2025" report provides an overview of the disease and global historical and forecasted epidemiological data of Oral Mucositis for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan till 2025.

Oral Mucositis is considered as one of the most common oral problems associated with cancer therapy. It is reported that Oral mucositis occurs in up to 20% to 40% of adult cancer patients receiving conventional chemotherapy for solid tumors, about 80% of patients receiving high-dose chemotherapy before haematopoietic stem cell transplantation, and almost all patients receiving radiotherapy for head and neck cancer. The Oral mucositis also occurs in the 70% of the patients with cancers of the mouth, oropharynx, hypopharynx, larynx, nasopharynx, and salivary glands. It has been reported that approximately 500,000 cases of oral mucositis occurs in U.S. The incidence of oral mucositis varies across populations of patients with cancer and is related to individual patient factors and the type of therapy being received.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house forecast model analysis by the team of industry experts.

Scope

  • The report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options
  • The report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5 and Japan from 2015-2025
  • The report includes the overall incidence, grade specific, gender specific and indication specific incidence of Oral Mucositis in the 7MM- United States, EU5 (France, Germany, Italy, Spain and UK) and Japan 

Table of Contents

1. Report Introduction

  • Overview
    • Oral Mucositis Incidence
    • Pathophysiology
    • Etiology and Risk Factors
    • Oral Mucositis Complications
    • Symptoms
    • Diagnosis
    • Interventions for Oral Mucositis
    • Chemotherapy Induced Oral Mucositis Treatment and Prevention
    • Treatment and Prevention Options for Patients receiving Hematopoietic Stem Cell Transplantation (HSCT)
  • Epidemiology Overview
  • Key Findings
  • Epidemiology of Oral Mucositis in 7 MM
    • Assumptions and Rationale
    • Incident Population of Oral Mucositis in 7MM
  • United States
    • Assumptions and Rationale
    • Incident Cases of Oral Mucositis in US
    • Grade Specific Incidence of Oral Mucositis in US
    • Gender Specific Incidence of Oral Mucositis in US
    • Indication Specific Incidence of Oral Mucositis in US
  • EU5
    • Assumptions and Rationale
  • France
    • Assumptions and Rationale
    • Incident Cases of Oral Mucositis in France
    • Grade Specific Incidence of Oral Mucositis in France
    • Gender Specific Incidence of Oral Mucositis in France
    • Indication Specific Incidence of Oral Mucositis in France
  • Germany
    • Assumptions and Rationale
    • Incident Cases of Oral Mucositis in Germany
    • Grade Specific Incidence of Oral Mucositis in Germany
    • Gender Specific Incidence of Oral Mucositis in Germany
    • Indication Specific Incidence of Oral Mucositis in Germany
  • Italy
    • Assumptions and Rationale
    • Incident Cases of Oral Mucositis in Italy
    • Grade Specific Incidence of Oral Mucositis in Italy
    • Gender Specific Incidence of Oral Mucositis in Italy
    • Indication Specific Incidence of Oral Mucositis in Italy
  • Spain
    • Assumptions and Rationale
    • Incident Cases of Oral Mucositis in Spain
    • Grade Specific Incidence of Oral Mucositis in Spain
    • Gender Specific Incidence of Oral Mucositis in Spain
    • Indication Specific Incidence of Oral Mucositis in Spain
  • United Kingdom
    • Assumptions and Rationale
    • Incident Cases of Oral Mucositis in United Kingdom
    • Grade Specific Incidence of Oral Mucositis in United Kingdom
    • Gender Specific Incidence of Oral Mucositis in United Kingdom
    • Indication Specific Incidence of Oral Mucositis in United Kingdom
  • Japan
    • Assumptions and Rationale
    • Incident Cases of Oral Mucositis in Japan
    • Grade Specific Incidence of Oral Mucositis in Japan
    • Gender Specific Incidence of Oral Mucositis in Japan
    • Indication Specific Incidence of Oral Mucositis in Japan

Appendix

List of Tables

  • Table 1: Incident Population of Oral Mucositis in 7MM (2015-2025)
  • Table 2: Incident Population of Oral Mucositis in United States (2015-2025)
  • Table 3: Grade Specific Incidence of Oral Mucositis in United States (2015-2025)
  • Table 4: Gender Specific Incidence of Oral Mucositis in United States (2015-2025)
  • Table 5: Indication Specific Incidence of Oral Mucositis in United States (2015-2025)
  • Table 6: Incident Population of Oral Mucositis in France (2015-2025)
  • Table 7: Grade Specific Incidence of Oral Mucositis in France (2015-2025)
  • Table 8: Gender Specific Incidence of Oral Mucositis in France (2015-2025)
  • Table 9: Indication Specific Incidence of Oral Mucositis in France (2015-2025)
  • Table 10: Incident Population of Oral Mucositis in Germany (2015-2025)
  • Table 11: Grade Specific Incidence of Oral Mucositis in Germany (2015-2025)
  • Table 12: Gender Specific Incidence of Oral Mucositis in Germany (2015-2025)
  • Table 13: Indication Specific Incidence of Oral Mucositis in Germany (2015-2025)
  • Table 14: Incident Population of Oral Mucositis in Italy (2015-2025)
  • Table 15: Grade Specific Incidence of Oral Mucositis in Italy (2015-2025)
  • Table 16: Gender Specific Incidence of Oral Mucositis in Italy (2015-2025)
  • Table 17: Indication Specific Incidence of Oral Mucositis in Italy (2015-2025)
  • Table 18: Incident Population of Oral Mucositis in Spain (2015-2025)
  • Table 19: Grade Specific Incidence of Oral Mucositis in Spain (2015-2025)
  • Table 20: Gender Specific Incidence of Oral Mucositis in Spain (2015-2025)
  • Table 21: Indication Specific Incidence of Oral Mucositis in Spain (2015-2025)
  • Table 22: Incident Population of Oral Mucositis in United Kingdom (2015-2025)
  • Table 23: Grade Specific Incidence of Oral Mucositis in United Kingdom (2015-2025)
  • Table 24: Gender Specific Incidence of Oral Mucositis in United Kingdom (2015-2025)
  • Table 25: Indication Specific Incidence of Oral Mucositis in United Kingdom (2015-2025)
  • Table 26: Incident Population of Oral Mucositis in Japan (2015-2025)
  • Table 27: Grade Specific Incidence of Oral Mucositis in Japan (2015-2025)
  • Table 28: Gender Specific Incidence of Oral Mucositis in Japan (2015-2025)
  • Table 29: Indication Specific Incidence of Oral Mucositis in Japan (2015-2025)

List of Figures

  • Figure 1: Incident Population of Oral Mucositis in 7MM (2015-2025)
  • Figure 2: Incident Population of Oral Mucositis in United States (2015-2025)
  • Figure 3: Grade Specific Incidence of Oral Mucositis in United States (2015-2025)
  • Figure 4: Gender Specific Incidence of Oral Mucositis in United States (2015-2025)
  • Figure 5: Indication Specific Incidence of Oral Mucositis in United States (2015-2025)
  • Figure 6: Incident Population of Oral Mucositis in France (2015-2025)
  • Figure 7: Grade Specific Incidence of Oral Mucositis in France (2015-2025)
  • Figure 8: Gender Specific Incidence of Oral Mucositis in France (2015-2025)
  • Figure 9: Indication Specific Incidence of Oral Mucositis in France (2015-2025)
  • Figure 10: Incident Population of Oral Mucositis in Germany (2015-2025)
  • Figure 11: Grade Specific Incidence of Oral Mucositis in Germany (2015-2025)
  • Figure 12: Gender Specific Incidence of Oral Mucositis in Germany (2015-2025)
  • Figure 13: Indication Specific Incidence of Oral Mucositis in Germany (2015-2025)
  • Figure 14: Incident Population of Oral Mucositis in Italy (2015-2025)
  • Figure 15: Grade Specific Incidence of Oral Mucositis in Italy (2015-2025)
  • Figure 16: Gender Specific Incidence of Oral Mucositis in Italy (2015-2025)
  • Figure 17: Indication Specific Incidence of Oral Mucositis in Italy (2015-2025)
  • Figure 18: Incident Population of Oral Mucositis in Spain (2015-2025)
  • Figure 19: Grade Specific Incidence of Oral Mucositis in Spain (2015-2025)
  • Figure 20: Gender Specific Incidence of Oral Mucositis in Spain (2015-2025)
  • Figure 21: Indication Specific Incidence of Oral Mucositis in Spain (2015-2025)
  • Figure 22: Incident Population of Oral Mucositis in United Kingdom (2015-2025)
  • Figure 23: Grade Specific Incidence of Oral Mucositis in United Kingdom (2015-2025)
  • Figure 24: Gender Specific Incidence of Oral Mucositis in United Kingdom (2015-2025)
  • Figure 25: Indication Specific Incidence of Oral Mucositis in United Kingdom (2015-2025)
  • Figure 26: Incident Population of Oral Mucositis in Japan (2015-2025)
  • Figure 27: Grade Specific Incidence of Oral Mucositis in Japan (2015-2025)
  • Figure 28: Gender Specific Incidence of Oral Mucositis in Japan (2015-2025)
  • Figure 29: Indication Specific Incidence of Oral Mucositis in Japan (2015-2025)
Back to Top